"Last I read they had 3-4 million? Per the sec docs"
How many ph 3 trials do your figures cover? And please, do not include any speculation that ipix will get a deal. Let's leave that to the professionals at ipix.
We've had this discussion. Net of short-term liabilities and not including what is owed to insiders they have no cash whatsoever. This has completely stymied the company, and the problem with Aspire being the only source of new cash is now obvious.
As the company approaches the Aspire cut-off of 25 cents I look for some sort of renegotiation with Aspire accompanied by a reverse split. This (or a miraculous white knight riding in to partner/acquire) may be the only thing that can stop this from going sub-penny.
News 
Market Data 
Discover 
